Parents of children with an incurable muscle-wasting condition have called on the Minister for Health to accelerate the ...

U.S. FDA successfully completed Pre-License Inspection; Company expects facility will meet all requirements to support ...

Capricor expressed confidence that the facility will meet the necessary requirements to support product licensure and ...

The parents of a nine-year-old boy battling a devastating muscle-wasting condition say new research could offer them more ...

Investigators found that making a few changes to a common patient-reported outcomes assessment improved its validity in patients with Duchenne muscular dystrophy.

Hundreds gathered to support muscular dystrophy research as the Muscular Dystrophy Association marked its 75th anniversary.

PepGen Inc. overstated prospects for its leading product candidate to treat a muscle-degenerating genetic disorder before facing negative responses to its clinical trial data and ultimately stopping ...

Cardiac complications in Duchenne muscular dystrophy (DMD) are the result of cardiac muscle involvement that accompanies the ...

Avidity shares early del-brax FSHD data showing improved mobility, strength, and safety; Phase 3 FORWARD trial now underway.

As diagnoses of autism spectrum disorder rise, a UNLV researcher's breakthrough could lead to new forms of treatment ...

Pathologic changes of the X-chromosome gene for dystrophin give rise to Duchenne muscular dystrophy (DMD), and dystrophin -- ...